PDF(670 KB)
Effect of urolithin A on postoperative cognitive dysfunction induced by isoflurane anesthesia in mice and its mechanism
Minhui XU, Xiaolei CHENG, Jiyan XU, Linhao JIANG, Tianjiao XIA
PDF(670 KB)
PDF(670 KB)
Effect of urolithin A on postoperative cognitive dysfunction induced by isoflurane anesthesia in mice and its mechanism
)Objective To discuss the improvement effect of uric acid （UA） on the postoperative cognitive dysfunction （POCD） in the mice anesthetized with isoflurane for a long duration， and to clarify its possible mechanism. Methods Twenty-four healthy male C57BL/6 mice were randomly divided into blank control group，anesthesia group， and UA group, and there were eight mice in each group. The mice in UA group were injected intraperitoneally with 200 μL UA solution daily for 2 d before anesthesia. The mice in blank control group and anesthesia group were given the same volume of saline; the mice in anesthesia group and UA group were used to prepare the models of long-duration isoflurane anesthesia， while the mice in blank control group were untreated. Y-maze tests was used to detect the alternation success rate， movement distances， and movement speeds of the mice in various groups； situational fear experiment was used to detect the percentages of freezing time； Western blotting method was used to detect the expression levels of interleukin (IL)-1β， IL-10， and mature brain-derived neurotrophic factor (mBDNF) proteins in hippocampus tissue of the mice in various groups. Results The Y-maze test results showed that compared with blank control group， the alternation success rate of the mice in anesthesia group was significantly decreased (P<0.01)； compared with anesthesia group， the alternation success rate of the mice in UA group was significantly increased (P<0.01). The situational fear experiment results showed that compared with blank control group, the percentage of freezing time of the mice in anesthesia group was significantly decreased (P<0.01)； compared with anesthesia group， the percentage of freezing time of the mice in UA group was significantly increased (P<0.05). The cued memory experiment resutls showed that there were no significant differences of the percentage of freezing time of the mice between various groups (P>0.05). The Western blotting results showed that compared with blank control group， the expression level of IL-1β protein in hippocampus tissue of the mice in anesthesia group was increased (P<0.01)， while the expression levels of IL-10 and mBDNF proteins were decreased (P<0.01)； compared with anesthesia group, the expression level of IL-1β protein in hippocampus tissue of the mice in UA group was decreased (P<0.05), and the expression levels of IL-10 and mBDNF proteins were increased (P<0.05 or P<0.01). Conclusion UA can improve the POCD in the mice, and its mechnasim may be related with its anti-inflammatory activity inhibiting the central inflammation and upregulating the mBDNF protein expression.
Urolithin A / Isoflurane / Postoperative cognitive dysfunction / Interleukin / Brain-derived neurotrophic factor
R742
| 1 | ING C， HEGARTY M K， PERKINS J W， et al. Duration of general anaesthetic exposure in early childhood and long-term language and cognitive ability［J］. Br J Anaesth， 2017， 119（3）： 532-540. |
| 2 | VUTSKITS L， XIE Z C. Lasting impact of general anaesthesia on the brain： mechanisms and relevance［J］. Nat Rev Neurosci， 2016， 17（11）： 705-717. |
| 3 | JIANG S， MIAO B， CHEN Y. Prolonged duration of isoflurane anesthesia impairs spatial recognition memory through the activation of JNK1/2 in the hippocampus of mice［J］. Neuroreport， 2017， 28（7）： 386-390. |
| 4 | ZUO C L， WANG C M， LIU J， et al. Isoflurane anesthesia in aged mice and effects of A1 adenosine receptors on cognitive impairment［J］. CNS Neurosci Ther， 2018， 24（3）： 212-221. |
| 5 | GONG Z， HUANG J Y， XU B， et al. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice［J］. J Neuroinflammation， 2019， 16（1）： 62. |
| 6 | LIN X H， YE X J， LI Q F， et al. Urolithin A prevents focal cerebral ischemic injury via attenuating apoptosis and neuroinflammation in mice［J］. Neuroscience， 2020， 448： 94-106. |
| 7 | FANG E F， HOU Y J， PALIKARAS K， et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease［J］. Nat Neurosci， 2019， 22（3）： 401-412. |
| 8 | BALLESTEROS-áLVAREZ J， NGUYEN W， SIVAPATHAM R， et al. Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease［J］. Geroscience， 2023， 45（2）： 1095-1113. |
| 9 | TICINESI A， MANCABELLI L， CARNEVALI L， et al. Interaction between diet and microbiota in the pathophysiology of Alzheimer’s disease： focus on polyphenols and dietary fibers［J］. J Alzheimers Dis， 2022， 86（3）： 961-982. |
| 10 | GORJI N， MOEINI R， MEMARIANI Z.Almond， hazelnut and walnut， three nuts for neuroprotection in Alzheimer’s disease： a neuropharmacological review of their bioactive constituents［J］. Pharmacol Res， 2018， 129： 115-127. |
| 11 | XIAO Y， LI K L， BIAN J， et al. Urolithin A attenuates diabetes-associated cognitive impairment by ameliorating intestinal barrier dysfunction via N-glycan biosynthesis pathway［J］. Mol Nutr Food Res， 2022， 66（9）： e2100863. |
| 12 | QIU J R， CHEN Y， ZHUO J， et al. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson’s disease model［J］. Neuropharmacology， 2022， 207： 108963. |
| 13 | GONZáLEZ-SARRíAS A， Nú?EZ-SáNCHEZ M á， TOMáS-BARBERáN F A， et al. Neuroprotective effects of bioavailable polyphenol-derived metabolites against oxidative stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells［J］. J Agric Food Chem， 2017， 65（4）： 752-758. |
| 14 | XU J L， YUAN C H， WANG G H， et al. Urolithins attenuate LPS-induced neuroinflammation in BV2Microglia via MAPK， Akt， and NF-κB signaling pathways［J］. J Agric Food Chem， 2018， 66（3）： 571-580. |
| 15 | BOAKYE Y D， GROYER L， HEISS E H. An increased autophagic flux contributes to the anti-inflammatory potential of urolithin A in macrophages［J］. Biochim Biophys Acta Gen Subj， 2018， 1862（1）： 61-70. |
| 16 | PIWOWARSKI J P， GRANICA S， ZWIERZY?SKA M， et al. Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials［J］. J Ethnopharmacol， 2014， 155（1）： 801-809. |
| 17 | PIWOWARSKI J P， KISS A K， GRANICA S， et al. Urolithins， gut microbiota-derived metabolites of ellagitannins， inhibit LPS-induced inflammation in RAW 264.7 murine macrophages［J］. Mol Nutr Food Res， 2015， 59（11）： 2168-2177. |
| 18 | COLUCCI-D’AMATO L， SPERANZA L， VOLPICELLI F. Neurotrophic factor BDNF， physiological functions and therapeutic potential in depression， neurodegeneration and brain cancer［J］. Int J Mol Sci， 2020， 21（20）： 7777. |
| 19 | WANG M Y， XIE Y H， QIN D D. Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases［J］. Brain Res Bull， 2021， 166： 172-184. |
| 20 | LEAL G， BRAMHAM C R， DUARTE C B. BDNF and hippocampal synaptic plasticity［J］. Vitam Horm， 2017， 104： 153-195. |
/
| 〈 |
|
〉 |
AI Summary
